Correction to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition

Tao Zhang; Suoyuan Li; Jingjie Li; Fei Yin; Yingqi Hua; Zhouying Wang; Binhui Lin; Hongsheng Wang; Dongqing Zou; Zifei Zhou; Jing Xu; Chengqing Yi; Zhengdong Cai

doi:10.1038/s41419-018-0911-4

Correction to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition

Cell Death Dis. 2018 Sep 5;9(9):902. doi: 10.1038/s41419-018-0911-4.

Authors

Tao Zhang¹, Suoyuan Li², Jingjie Li³, Fei Yin², Yingqi Hua², Zhouying Wang², Binhui Lin², Hongsheng Wang², Dongqing Zou², Zifei Zhou², Jing Xu², Chengqing Yi⁴, Zhengdong Cai⁵

Affiliations

¹ Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [email protected].
² Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
³ The Institute of Cell Metabolism and Disease, Shanghai Key Laboratory of Pancreatic Cancer, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [email protected].
⁵ Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [email protected].

Abstract

Since publication of this article, the authors have noticed errors in Fig. 1e (the merge image of control group) and Fig. 5e (Pec. 50 mg/kg group). As a result of the misfiling of the data, incorrect images were inadvertently inserted in Figs. 1e and 5e during figure preparation. The correct figures are given below.

Publication types

Published Erratum